Medicine passport

Tysabri 300 mg (20 mg/ml) concentraat voor oplossing voor injectie 300 mg + 20 mg/ml

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Natalizumab
Strength
300 mg + 20 mg/ml
Form
concentraat voor oplossing voor infusie
ATC code
L04AG03
Registered in
Netherlands · Biogen Netherlands B.V.
Prescription
Prescription only
RVG
EU/1/06/346

Source: Geneesmiddeleninformatiebank · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

No other register Mediclarum reads lists a product with this active substance, strength and form.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/nl/en/medicines/tysabri-300-mg-20-mg-ml-concentraat-voor-oplossing-voor-injectie-300-mg